Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03837899
Title Durvalumab and Tremelimumab for Pediatric Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: child
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU

Facility Status City State Zip Country Details
Research Site Baltimore Maryland 21231 United States Details
Research Site Boston Massachusetts 02115 United States Details
Research Site New Hyde Park New York 11040 United States Details
Research Site Oklahoma City Oklahoma 73104 United States Details
Research Site Charleston South Carolina 29425 United States Details
Research Site Lille Cedex 59020 France Details
Research Site Marseille 13385 France Details
Research Site Paris Cedex 05 75248 France Details
Research Site Köln 50924 Germany Details
Research Site Genova 16100 Italy Details
Research Site Milano 20133 Italy Details
Research Site Rome 00165 Italy Details
Research Site Torino 10126 Italy Details
Research Site Utrecht 3584 CS Netherlands Details
Research Site Barcelona 08035 Spain Details
Research Site Madrid 28009 Spain Details
Research Site Leeds LS1 3EX United Kingdom Details
Research Site London WC1N 3JH United Kingdom Details
Research Site Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field